Literature DB >> 26628675

Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Hypertensive Patients With Primary Hyperaldosteronemia: Role of 5,6,7,8-Tetrahydrobiopterin Oxidation and Endothelial Nitric Oxide Synthase Uncoupling.

Long Chen1, Mei-Lin Ding1, Fang Wu1, Wen He1, Jin Li1, Xiao-Yu Zhang1, Wen-Li Xie1, Sheng-Zhong Duan1, Wen-Hao Xia2, Jun Tao2.   

Abstract

Although hyperaldosteronemia exerts detrimental impacts on vascular endothelium in addition to elevating blood pressure, the effects and molecular mechanisms of hyperaldosteronemia on early endothelial progenitor cell (EPC)-mediated endothelial repair after arterial damage are yet to be determined. The aim of this study was to investigate the endothelial repair capacity of early EPCs from hypertensive patients with primary hyperaldosteronemia (PHA). In vivo endothelial repair capacity of early EPCs from PHAs (n=20), age- and blood pressure-matched essential hypertension patients (n=20), and age-matched healthy subjects (n=20) was evaluated by transplantation into a nude mouse carotid endothelial denudation model. Endothelial function was evaluated by flow-mediated dilation of brachial artery in human subjects. In vivo endothelial repair capacity of early EPCs and flow-mediated dilation were impaired both in PHAs and in essential hypertension patients when compared with age-matched healthy subjects; however, the early EPC in vivo endothelial repair capacity and flow-mediated dilation of PHAs were impaired more severely than essential hypertension patients. Oral spironolactone improved early EPC in vivo endothelial repair capacity and flow-mediated dilation of PHAs. Increased oxidative stress, oxidative 5,6,7,8-tetrahydrobiopterin degradation, endothelial nitric oxide synthase uncoupling and decreased nitric oxide production were found in early EPCs from PHAs. Nicotinamide adenine dinucleotide phosphate oxidase subunit p47(phox) knockdown or 5,6,7,8-tetrahydrobiopterin supplementation attenuated endothelial nitric oxide synthase uncoupling and enhanced in vivo endothelial repair capacity of early EPCs from PHAs. In conclusion, PHAs exhibited more impaired endothelial repair capacity of early EPCs than did essential hypertension patients independent of blood pressure, which was associated with mineralocorticoid receptor-dependent oxidative stress and subsequently 5,6,7,8-tetrahydrobiopterin degradation and endothelial nitric oxide synthase uncoupling.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; hypertension; nitric oxide synthase type III; oxidative stress; sapropterin

Mesh:

Substances:

Year:  2015        PMID: 26628675     DOI: 10.1161/HYPERTENSIONAHA.115.06597

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

2.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

Review 3.  The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease.

Authors:  Ana P Davel; Imran J Anwar; Iris Z Jaffe
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

4.  Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion.

Authors:  Feng-Jin Shao; Xiao-Ling Guo; Jia-Xue Xu; Rui Liu; Dan-Yue Li; Qing-Hao Li; Ting Zhou; Cun Fang; Xun Tan
Journal:  Respir Res       Date:  2022-10-23

5.  Fasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury-Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells.

Authors:  Jiapan Sun; Tingying Zhang; Li Zhang; Bin Ke; Jian Qin
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-27       Impact factor: 2.629

6.  Rescue of hypertension-related impairment of angiogenesis by therapeutic ultrasound.

Authors:  Zhao-Yang Lu; Rui-Lin Li; Hong-Sheng Zhou; Jing-Juan Huang; Jia Qi; Zhi-Xiao Su; Lan Zhang; Yue Li; Yi-Qin Shi; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 7.  Endothelial progenitor cells as critical mediators of environmental air pollution-induced cardiovascular toxicity.

Authors:  Parul Singh; Timothy E O'Toole; Daniel J Conklin; Bradford G Hill; Petra Haberzettl
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-19       Impact factor: 4.733

8.  Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex.

Authors:  Velia Cassano; Giovanni Tripepi; Maria Perticone; Sofia Miceli; Irene Scopacasa; Giuseppe Armentaro; Marta Greco; Raffaele Maio; Marta Letizia Hribal; Giorgio Sesti; Francesco Perticone; Angela Sciacqua
Journal:  Hypertens Res       Date:  2021-09-01       Impact factor: 3.872

9.  Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Masaaki Kubota; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Yoshio Kobayashi; Hirotaka Takizawa; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Sohei Kobayashi; Kazuyuki Matsushita; Fumio Nomura; Hisahiro Matsubara; Makoto Sumazaki; Masaaki Ito; Satoshi Yajima; Hideaki Shimada; Katsuro Iwase; Hiromi Ashino; Hao Wang; Kenichiro Goto; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate; Takaki Hiwasa
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Xinkeshu Improves Endothelial Function and Augments Reendothelialization Capacity in Coronary Artery Disease with Anxiety/Depression.

Authors:  Jiapan Sun; Meiling Zhou; Guanghui Lv; Wenling Li; Yuanya Liu; Jiawen Liang; Jianning Zhang; Shijun Zhang; Yuanfei Deng; Jun Tao
Journal:  Oxid Med Cell Longev       Date:  2021-07-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.